QIAGEN NV (QGEN)
35.10
+0.86
(+2.51%)
USD |
NYSE |
May 20, 16:00
35.10
0.00 (0.00%)
Pre-Market: 20:00
QIAGEN Market Cap : 7.231B for May 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CDT Equity, Inc. | 6.024M |
| Thermo Fisher Scientific, Inc. | 167.85B |
| ICON plc | 8.781B |
| InflaRx NV | 360.13M |
| Adaptive Biotechnologies Corp. | 2.234B |
Market Cap Related Metrics
| PE Ratio | 18.13 |
| PS Ratio | 3.476 |
| PEG Ratio | 0.0584 |
| Price to Book Value | 2.170 |
| Price to Free Cash Flow | 18.07 |
| Price | 35.10 |
| Earnings Yield | 5.51% |
| PEGY Ratio | 0.0564 |
| Operating PE Ratio | 14.24 |
| Normalized PE Ratio | 15.93 |